AMBU.BAmbuAMBU.B info
$18.82info1.80%24h
Global rank
Market cap$4.90B
Change 7d4.06%
YTD Performance28.69%
SP500 benchmarkOutperform
P/E29.41
P/S7.40
Revenue$662.38M
Earnings$23.30M
Dividend yield-

Ambu (AMBU.B) Stock Overview

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides anaesthesia, and patient monitoring and diagnostics products. The company offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

AMBU.B Stock Information

Symbol
AMBU.B
Address
Baltorpbakken 13Ballerup, 2750Denmark
Founded
-
Trading hours
-
Website
https://www.ambu.com
Country
🇩🇰 Denmark
Phone Number
45 72 25 20 00

Ambu (AMBU.B) Price Chart

-
Value:-

Ambu Overview: Key Details and Summary

Stock data
2023
Change
Price
$18.82
N/A
Market Cap
$4.90B
N/A
Shares Outstanding
260.48M
2.56%
Employees
4.62K
N/A
Shareholder Equity
5.39B
26.57%
Valuation
2023
Change
P/E Ratio
29.41
N/A
P/S Ratio
7.40
N/A
P/B Ratio
0.91
N/A
Growth
2023
Change
Return on Equity
0.0043
N/A
Earnings
2023
Change
Revenue
$662.38M
N/A
Earnings
$23.30M
N/A
EPS
0.64
N/A
Earnings Yield
0.034
N/A
Gross Margin
0.5682
N/A
Operating Margin
0.0632
N/A
Net income margin
0.0352
N/A
Financial Strength
2023
Change
Total Assets
$951.46M
N/A
Total Debt
$81.01M
N/A
Cash on Hand
$21.78M
N/A
Debt to Equity
0.0377
-60.79%
Cash to Debt
0.2688
165.24%
Current Ratio
$2.13
7.41%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org